A tellurylsulfide bond-containing biopolymer nanogel was first fabricated to achieve smart drug release. The reductive nanogel exhibited highly sensitive reduction-responsiveness, fast internalization, and efficient anticancer therapy. This approach displays a new potential of tellurylsulfide bond-containing nanocarriers for drug delivery.
No takes yet. Share an insight, caveat, or question.
Xia et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: